Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LFST NYSE:OSH NASDAQ:PRVA NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLFSTLifeStance Health Group$4.37+13.2%$4.77$3.74▼$8.61$1.50B1.132.47 million shs7.39 million shsOSHOak Street Health$39.00$37.57$13.29▼$39.00$9.52B2.235.76 million shsN/APRVAPrivia Health Group$20.58+5.5%$21.30$16.47▼$26.09$2.38B0.81.02 million shs1.79 million shsWGSGeneDx$105.13-0.8%$83.61$28.86▼$117.75$3.02B2.02980,924 shs417,351 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLFSTLifeStance Health Group+13.21%+15.30%-8.00%-23.73%-20.69%OSHOak Street Health0.00%0.00%0.00%0.00%0.00%PRVAPrivia Health Group+5.48%+9.12%-2.92%-17.75%+12.64%WGSGeneDx-0.77%+3.47%+14.42%+78.40%+261.27%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLFSTLifeStance Health Group3.2067 of 5 stars3.44.00.00.02.72.50.6OSHOak Street HealthN/AN/AN/AN/AN/AN/AN/AN/APRVAPrivia Health Group3.7513 of 5 stars3.54.00.00.01.83.31.9WGSGeneDx3.0752 of 5 stars1.44.00.00.03.45.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLFSTLifeStance Health Group 2.86Moderate Buy$8.5094.51% UpsideOSHOak Street Health 0.00N/AN/AN/APRVAPrivia Health Group 3.00Buy$28.3837.92% UpsideWGSGeneDx 2.75Moderate Buy$101.63-3.33% DownsideCurrent Analyst Ratings BreakdownLatest OSH, PRVA, LFST, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $9.008/4/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$110.00 ➝ $120.007/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $95.007/25/2025LFSTLifeStance Health GroupBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$8.007/9/2025PRVAPrivia Health GroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$30.00 ➝ $28.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.005/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$8.505/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.00(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLFSTLifeStance Health Group$1.25B1.36$0.04 per share97.34$3.78 per share1.16OSHOak Street Health$2.16B4.40N/AN/A($1.10) per share-35.45PRVAPrivia Health Group$1.74B1.45$0.19 per share108.12$6.02 per share3.42WGSGeneDx$305.45M9.82$1.02 per share103.54$9.71 per share10.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLFSTLifeStance Health Group-$57.44M-$0.10N/AN/AN/A-1.23%-1.12%-0.77%N/AOSHOak Street Health-$509.20M-$2.21N/AN/AN/A-23.57%N/A-25.08%N/APRVAPrivia Health Group$14.39M$0.12187.1176.223.310.78%2.13%1.25%N/AWGSGeneDx-$52.29M$0.052,102.6050.30N/A0.39%16.51%9.35%N/ALatest OSH, PRVA, LFST, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million8/7/2025Q2 2025PRVAPrivia Health Group$0.05$0.02-$0.03$0.02$466.97 million$521.15 million7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLFSTLifeStance Health GroupN/AN/AN/AN/AN/AOSHOak Street HealthN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLFSTLifeStance Health Group0.191.471.47OSHOak Street HealthN/A1.411.41PRVAPrivia Health GroupN/A1.651.88WGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLFSTLifeStance Health Group85.50%OSHOak Street Health92.04%PRVAPrivia Health Group94.48%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipLFSTLifeStance Health Group3.20%OSHOak Street Health11.55%PRVAPrivia Health Group10.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLFSTLifeStance Health Group10,218388.88 million376.43 millionOptionableOSHOak Street Health6,000244.00 million215.82 millionNot OptionablePRVAPrivia Health Group1,140121.92 million108.88 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableOSH, PRVA, LFST, and WGS HeadlinesRecent News About These CompaniesGeneDx Holdings' (NASDAQ:WGS) Performance Is Even Better Than Its Earnings SuggestAugust 8 at 8:15 PM | finance.yahoo.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 8 at 4:43 PM | prnewswire.comGeneDx Holdings Corp. (NASDAQ:WGS) is Gagnon Securities LLC's 5th Largest PositionAugust 8 at 6:52 AM | marketbeat.comThoroughbred Financial Services LLC Has $700,000 Stake in GeneDx Holdings Corp. (NASDAQ:WGS)August 8 at 4:34 AM | marketbeat.comGeneDx (NASDAQ:WGS) versus Organon & Co. (NYSE:OGN) Head to Head SurveyAugust 8 at 3:25 AM | americanbankingnews.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 7 at 7:01 PM | globenewswire.comShould You Buy GeneDx Holdings Corp. (WGS) After Golden Cross?August 7 at 10:55 AM | zacks.comGENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. ...August 6 at 8:13 PM | gurufocus.comGENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the FirmAugust 6 at 7:01 PM | globenewswire.comScott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)August 6 at 9:30 AM | globenewswire.comWestfield Capital Management Co. LP Buys New Shares in GeneDx Holdings Corp. (NASDAQ:WGS)August 6 at 5:39 AM | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) StockAugust 5, 2025 | marketbeat.comAlberta Investment Management Corp Buys New Shares in GeneDx Holdings Corp. (NASDAQ:WGS)August 5, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Position Increased by TD Asset Management IncAugust 5, 2025 | marketbeat.comEnvestnet Asset Management Inc. Buys 4,178 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)August 5, 2025 | marketbeat.comRosen Law Firm Encourages GeneDx Holdings Corp. ...August 3, 2025 | gurufocus.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 3, 2025 | prnewswire.comGeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Buy RatingAugust 3, 2025 | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...August 2, 2025 | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 2, 2025 | globenewswire.com15,317 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Universal Beteiligungs und Servicegesellschaft mbHAugust 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOSH, PRVA, LFST, and WGS Company DescriptionsLifeStance Health Group NASDAQ:LFST$4.37 +0.51 (+13.21%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$4.36 0.00 (-0.11%) As of 08/8/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Oak Street Health NYSE:OSHOak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.Privia Health Group NASDAQ:PRVA$20.58 +1.07 (+5.48%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$20.58 +0.01 (+0.02%) As of 08/8/2025 05:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.GeneDx NASDAQ:WGS$105.13 -0.82 (-0.77%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$106.70 +1.57 (+1.49%) As of 08/8/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down DraftKings Posts Record Quarter, Eyes Profitability Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
